- Home
- GNLX vs VGI Comparison
GNLX vs VGI Comparison
Compare GNLX & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- VGI
- Stock Information
- Founded
- GNLX 2001
- VGI 2012
- Country
- GNLX United States
- VGI United States
- Employees
- GNLX N/A
- VGI N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- GNLX Health Care
- VGI Finance
- Exchange
- GNLX Nasdaq
- VGI Nasdaq
- Market Cap
- GNLX 112.5M
- VGI N/A
- IPO Year
- GNLX 2023
- VGI N/A
- Fundamental
- Price
- GNLX $3.44
- VGI $7.80
- Analyst Decision
- GNLX Strong Buy
- VGI
- Analyst Count
- GNLX 4
- VGI 0
- Target Price
- GNLX $17.75
- VGI N/A
- AVG Volume (30 Days)
- GNLX 152.2K
- VGI 46.0K
- Earning Date
- GNLX 08-13-2025
- VGI 01-01-0001
- Dividend Yield
- GNLX N/A
- VGI 12.66%
- EPS Growth
- GNLX N/A
- VGI N/A
- EPS
- GNLX N/A
- VGI N/A
- Revenue
- GNLX N/A
- VGI N/A
- Revenue This Year
- GNLX N/A
- VGI N/A
- Revenue Next Year
- GNLX N/A
- VGI N/A
- P/E Ratio
- GNLX N/A
- VGI N/A
- Revenue Growth
- GNLX N/A
- VGI N/A
- 52 Week Low
- GNLX $1.60
- VGI $6.68
- 52 Week High
- GNLX $5.89
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- GNLX 65.71
- VGI 51.62
- Support Level
- GNLX $2.80
- VGI $7.82
- Resistance Level
- GNLX $3.61
- VGI $7.93
- Average True Range (ATR)
- GNLX 0.22
- VGI 0.06
- MACD
- GNLX 0.05
- VGI -0.00
- Stochastic Oscillator
- GNLX 80.23
- VGI 39.29
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.